Man Group
OCUL icon

Man Group’s Ocular Therapeutix OCUL Stock Holding History

Man Group’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5M Buy
177,468
+131,379
+285% +$1.25M ﹤0.01% 1681
2025
Q4 		$560K Buy
+46,089
New +$560K ﹤0.01% 1863
2024
Q2 		– Sell
-21,543
Closed -$196K – 2197
2024
Q1 		$196K Buy
+21,543
New +$153K ﹤0.01% 2013
2023
Q3 		– Hold
0
– – – 1865
2022
Q1 		– Sell
-106,970
Closed -$746K – 2304
2021
Q4 		$746K Buy
+106,970
New +$831K ﹤0.01% 1413
2020
Q1 		– Sell
-760,490
Closed -$3M – 1805
2019
Q4 		$3M Sell
760,490
-1,148,988
-60% -$3.99M 0.01% 1191
2019
Q3 		$5.8M Sell
1,909,478
-248,671
-12% -$1.11M 0.02% 808
2019
Q2 		$9.5M Buy
2,158,149
+434,693
+25% +$1.61M 0.03% 653
2019
Q1 		$6.84M Buy
1,723,456
+535,948
+45% +$2.15M 0.03% 751
2018
Q4 		$4.73M Buy
1,187,508
+684,391
+136% +$3.77M 0.02% 797
2018
Q3 		$3.46M Buy
+503,117
New +$3.16M 0.01% 1189

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return